Amalgamated Bank United Therapeutics Corp Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

A detailed history of Amalgamated Bank transactions in United Therapeutics Corp stock. As of the latest transaction made, Amalgamated Bank holds 21,565 shares of UTHR stock, worth $7.78 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
21,565
Previous 25,406 15.12%
Holding current value
$7.78 Million
Previous $8.09 Million 4.51%
% of portfolio
0.06%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$311.04 - $363.55 $1.19 Million - $1.4 Million
-3,841 Reduced 15.12%
21,565 $7.73 Million
Q2 2024

Aug 12, 2024
SELL
$228.26 - $319.04 $496,008 - $693,273
-2,173 Reduced 7.88%
25,406 $8.09 Million
Q1 2024

Apr 23, 2024
SELL
$210.76 - $249.51 $304,758 - $360,791
-1,446 Reduced 4.98%
27,579 $6.34 Million
Q4 2023

Feb 06, 2024
SELL
$214.88 - $256.94 $176,201 - $210,690
-820 Reduced 2.75%
29,025 $6.38 Million
Q3 2023

Nov 08, 2023
SELL
$211.82 - $248.24 $92,353 - $108,232
-436 Reduced 1.44%
29,845 $6.74 Million
Q2 2023

Aug 11, 2023
SELL
$205.19 - $232.99 $356,004 - $404,237
-1,735 Reduced 5.42%
30,281 $6.68 Million
Q1 2023

May 02, 2023
SELL
$212.99 - $276.17 $204,896 - $265,675
-962 Reduced 2.92%
32,016 $7.17 Million
Q4 2022

Feb 10, 2023
SELL
$205.95 - $280.43 $17,093 - $23,275
-83 Reduced 0.25%
32,978 $9.17 Million
Q3 2022

Nov 09, 2022
BUY
$203.3 - $244.17 $64,852 - $77,890
319 Added 0.97%
33,061 $6.92 Million
Q2 2022

Aug 15, 2022
BUY
$174.81 - $241.14 $202,429 - $279,240
1,158 Added 3.67%
32,742 $7.72 Million
Q1 2022

Jun 30, 2022
SELL
$166.16 - $213.96 $186,099 - $239,635
-1,120 Reduced 3.42%
31,584 $5.67 Million
Q4 2021

Feb 15, 2022
SELL
$184.32 - $216.08 $248,279 - $291,059
-1,347 Reduced 3.96%
32,704 $7.07 Million
Q3 2021

Oct 29, 2021
SELL
$179.86 - $214.88 $585,084 - $699,004
-3,253 Reduced 8.72%
34,051 $6.29 Million
Q2 2021

Aug 16, 2021
BUY
$170.47 - $211.93 $5.43 Million - $6.76 Million
31,881 Added 587.88%
37,304 $6.69 Million
Q1 2021

May 13, 2021
SELL
$153.94 - $174.85 $55,264 - $62,771
-359 Reduced 6.21%
5,423 $907,000
Q4 2020

Feb 12, 2021
BUY
$101.87 - $151.79 $1,528 - $2,276
15 Added 0.26%
5,782 $877,000
Q3 2020

Oct 30, 2020
SELL
$99.9 - $121.13 $2,397 - $2,907
-24 Reduced 0.41%
5,767 $582,000
Q2 2020

Aug 10, 2020
SELL
$92.74 - $125.82 $367,806 - $499,002
-3,966 Reduced 40.65%
5,791 $701,000
Q1 2020

May 13, 2020
SELL
$79.39 - $115.35 $17,068 - $24,800
-215 Reduced 2.16%
9,757 $925,000
Q4 2019

Feb 13, 2020
BUY
$78.31 - $95.34 $82,147 - $100,011
1,049 Added 11.76%
9,972 $878,000
Q3 2019

Nov 13, 2019
SELL
$74.85 - $85.99 $11,751 - $13,500
-157 Reduced 1.73%
8,923 $712,000
Q2 2019

Aug 14, 2019
BUY
$76.06 - $120.81 $34,683 - $55,089
456 Added 5.29%
9,080 $709,000
Q1 2019

May 15, 2019
BUY
$107.15 - $126.84 $19,608 - $23,211
183 Added 2.17%
8,624 $1.01 Million
Q4 2018

Feb 15, 2019
SELL
$101.4 - $128.73 $11,965 - $15,190
-118 Reduced 1.38%
8,441 $919,000
Q3 2018

Nov 14, 2018
SELL
$113.81 - $129.46 $2,731 - $3,107
-24 Reduced 0.28%
8,559 $1.1 Million
Q2 2018

Jul 18, 2018
SELL
$101.14 - $118.31 $2,225 - $2,602
-22 Reduced 0.26%
8,583 $971,000
Q1 2018

May 22, 2018
SELL
$107.21 - $151.94 $8,576 - $12,155
-80 Reduced 0.92%
8,605 $967,000
Q4 2017

Feb 13, 2018
BUY
$118.58 - $151.28 $57,985 - $73,975
489 Added 5.97%
8,685 $1.29 Million
Q3 2017

Nov 09, 2017
BUY
$114.6 - $136.81 $939,261 - $1.12 Million
8,196
8,196 $960,000

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email